Alpco diagnostics are a supplier of immunoassay kits for the medical research community.
Their kits are developed by scientists committed to supporting those who work in physiology and disease research.

ALPCO provide a broad portfolio of life science research tools for academic, pre-clinical and clinical use, including primary antibodies, flow cytometry reagents, recombinant proteins, and products for HPLC and LC-MS/MS, but are best known for providing, as they put it: “Immunoassays Beyond the Ordinary.”

ALPCO have a reputation for quality among their customers because they focus on providing immunoassays which are highly sensitive, specific and reproducible with a broad dynamic range that allows for fewer dilution steps and therefore reduced systematic error.

They have recently developed the new STELLUX™ range of chemiluminescent immunosorbent assays. These combine exquisite sensitivity, ease of use, and outstanding reliability which comes from extensive testing and characterisation.


Product CategoriesAlpco Diagnostics

Immunoassays

HPLC and LC/MS-MS reagents

Purified antibodies

Recombinant proteins

Flow cytometry reagents

Chemiluminescent assays

 


Biomarkers for Diabetes & Obesity

Energy homeostasis is a well-regulated process that depends on the coordination between feeding behavior and energy expenditure. The control of energy homeostasis in humans has received much attention in recent years due to alterations caused by the onset of conditions such as obesity and diabetes. ALPCO offers numerous assay kits to assist both academic and industry researchers with quantification of analytes associated with energy homeostasis.


Bone Metabolism: The Cycle of Bone Growth and Resorption

Bone metabolism is a continual cycle of bone growth and resorption that is carefully orchestrated by the dynamic relationship between osteoclasts, osteoblasts Read More…

Understanding the Role of Energy Homeostasis in Diabetes

Introduction The prevalence of diabetes and obesity has been on the rise for several decades and research has demonstrated that Read More…

Simplify Stool Sample Processing

Introduction We understand the challenges facing lab managers and directors who need to continuously improve workflow efficiency and implement new Read More…

Measuring Pancreatic Elastase to Diagnose Pancreatic Disease

Many digestive system disorders and diseases can  present similar types of symptoms including bloating, diarrhea, constipation, and weight gain/loss. In Read More…

Heart Disease Biomarkers in Diabetes Research

Introduction Cardiovascular disease (CVD) encompasses a constellation of diseases related to the heart and circulatory system. Despite efforts to understand Read More…

Measuring Calprotectin When Studying Inflammatory Bowel Diseases

Calprotectin (MRP 8/14, S100 A8/A9) is an immunomodulatory protein accounting for up to 60% of cytosolic protein in neutrophil granulocytes Read More…

Physiological Actions of Natriuretic Peptides

Introduction Humans have at least 50 discovered hormones managing vital biological functions in the body. These hormones are produced by Read More…

Stool-Based Biomarkers to Differentiate Between IBD and IBS

What are IBD and IBS? Inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) are two different gastrointestinal tract issues Read More…

Early Detection of Diabetic Kidney Disease with Biomarkers

Introduction Over one third of diabetics will develop diabetic kidney disease (DKD) in their lifetime1. Despite the large amount of Read More…

Investigating Bioactive Leptin in Obesity Research

The Biology of Leptin Leptin is a hormone composed of 167 amino acids and is primarily produced by adipocytes, therefore Read More…

Developing A Chemiluminescent Immunoassay Platform

Introduction ALPCO developed STELLUX® as a chemiluminescent immunoassay platform aimed at detecting key biomarkers in the life science research and Read More…

The Changing Roles of Bone Remodeling Biomarkers

Introduction Bones are traditionally known for their support, protection and movement properties, as well as their role in the processes Read More…

Emerging Biomarker Research in NAFLD and NASH

Nonalcoholic fatty liver disease (NAFLD) is becoming the most common chronic liver disease in the western hemisphere affecting 1 in Read More…

Obesity Induced Adipose Tissue Dysfunction and NAFLD

Obesity is a known risk factor for developing metabolic diseases such as non-alcoholic fatty liver disease (NAFLD)1. An increasing amount Read More…

Classes of Biologics for the Treatment of IBD

Monoclonal antibody (mAb) biologics have been used to treat inflammatory bowel disease (IBD) for several years. Various classes of biologics Read More…

Researching Therapeutic Drug Monitoring for IBD

Multiple classes of biologics are available for the treatment of inflammation associated with inflammatory bowel disease (IBD) which ultimately improves Read More…

Therapeutic Drug Monitoring of Biosimilars in Autoimmune Diseases

Anti-TNF-alpha biologics have been proven to be effective treatments for autoimmune diseases such as rheumatoid arthritis (RA) and inflammatory bowel Read More…

Challenges When Treating IBD with Biologics

Monoclonal antibody (mAbs) biologics have been used to treat inflammatory bowel disease (IBD) for 20 years1. Despite the successful use Read More…

The Generation and Function of Active GLP-1

Active glucagon-like peptide-1 (GLP-1) is a member of the incretin hormone family and is generated as a result of post Read More…

The Relationship Between Glucagon and Energy Homeostasis

Glucagon is a gut hormone generated as a result of post translational modifications during proglucagon processing in the pancreas1,2,3. Research Read More…